HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-targeted HAART

Agency: NIH/NIMH
Agency Award Number: R01MH058076

To evaluate the efficacy of a CNS-targeted antiretroviral treatment (ART) strategy for individuals with HIV-associated neurocognitive impairment (HNCI) through a randomized clinical trial.

Copyright ©2022 HIV Neurobehavioral Research Program | University of California, San Diego
For questions regarding this site, please contact the webmaster